KURA ONCOLOGY INC (KURA:NASDAQ)
$9.68 0.74 (8.2774%)
Analysed KURA ONCOLOGY INC (KURA:NASDAQ) News Sources
How The Kura Oncology (KURA) Narrative Is Shifting With Komzifti Launch And New Analyst Targets
19-04-2026
yahoo.com
Sector Update: Health Care Stocks Advance Late Afternoon
17-04-2026
yahoo.com
Sector Update: Health Care Stocks Higher Friday Afternoon
17-04-2026
yahoo.com
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
17-04-2026
yahoo.com
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
09-04-2026
yahoo.com
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Implied Volatility Surging for Kura Oncology Stock Options
12-03-2026
yahoo.com
How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets
08-03-2026
yahoo.com
Kura Oncology Q4 Earnings Call Highlights
06-03-2026
marketbeat.com
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ...
05-03-2026
yahoo.com
What is the current price of KURA ONCOLOGY INC (KURA:NASDAQ)?
The current price of KURA ONCOLOGY INC (KURA:NASDAQ) is $9.68.
KURA ONCOLOGY INC (KURA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KURA ONCOLOGY INC (KURA:NASDAQ) since the previous trading day is $0.74.
KURA ONCOLOGY INC (KURA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KURA ONCOLOGY INC (KURA:NASDAQ) since the previous trading day is 8.2774%.
What is the most recent average sentiment score for KURA ONCOLOGY INC (KURA:NASDAQ)?
The most recent average sentiment score for KURA ONCOLOGY INC (KURA:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for KURA ONCOLOGY INC (KURA:NASDAQ)?
The most recent sentiment for KURA ONCOLOGY INC (KURA:NASDAQ) is .
SEC-8K** Filing Available For KURA ONCOLOGY INC (KURA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.